HEATHER GUILLORY: Open Payments
NPI 1568777936 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 21 payments from 11 companies in 2025. Trend: 2023 $520 · 2024 $570 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $126 |
| Abbott Laboratories | 6 | $111 |
| ABBVIE INC. | 2 | $36 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Boston Scientific Corporation | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Antares Pharma, Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: Veozah, FREESTYLE LIBRE 3, INJECTAFER, WATCHMAN FLX, REXULTI, XYOSTED, QULIPTA, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
